First Week of April 2026 Options Trading For Lenz Therapeutics

An analysis of options strategies for Lenz Therapeutics (LENZ), currently trading at $39.00, highlights two potential approaches for investors. Selling a $35.00 strike put contract could yield a 16.86% return (25.43% annualized) if it expires worthless, with a 69% probability, effectively lowering the cost basis to $29.10 if assigned. Alternatively, a covered call strategy using the $45.00 strike offers a potential 32.56% total return if the stock is called away by April 2026, or a 17.18% premium return (25.91% annualized) if the call expires worthless, with a 46% probability. These strategies leverage LENZ's implied volatility of 75-76% to offer attractive yield-enhancement opportunities.

Analysis

Analysis of options contracts on Lenz Therapeutics (LENZ), currently trading at $39.00 per share, highlights two distinct yield-enhancement strategies driven by elevated volatility. The implied volatility in the put and call options is high, at 75% and 76% respectively, running slightly ahead of the stock's actual trailing twelve-month volatility of 71%. This premium in implied volatility makes selling options particularly attractive. For investors looking to initiate a position, selling the $35.00 strike put contract offers a way to collect a $5.90 premium, thereby lowering the potential cost basis to $29.10 if assigned. Analytical models suggest a 69% probability of this out-of-the-money put expiring worthless, which would result in a 16.86% return on the cash commitment, or 25.43% annualized. For existing shareholders, a covered call strategy using the $45.00 strike could generate a 17.18% return boost (25.91% annualized) if the option expires worthless, an outcome with a 46% probability. Alternatively, if the stock is called away at the April 2026 expiration, the strategy would yield a total return of 32.56%, capping further upside beyond the $45.00 strike price.

Key Decisions for Investors

• Investors bullish on LENZ but seeking a more favorable entry point could consider selling the $35.00 cash-secured put to either acquire shares at an effective cost of $29.10 or generate a significant annualized yield of 25.43%.
• Current shareholders aiming to generate income from their position could sell the $45.00 covered call, which offers an attractive annualized yield while still permitting stock price appreciation up to the strike price.
• Be aware that the substantial potential returns from these options strategies are a direct result of high implied volatility, which indicates the market expects significant price swings and carries inherent risk of large adverse movements in the underlying stock.